Investigate the Responsiveness of the Erectile Quality Scale to Vardenafil Flexible Dose vs Placebo in Males With Erectile Dysfunction (ED)
Completed · Phase 4 · Has a placebo group
Conditions studied: Erectile Dysfunction
In brief
This study was conducted to evaluate in adult men with erectile dysfunction (often called impotence), the effect of vardenafil HCl on the quality of their erections. Many men experience occasional erectile problems during their lives. The causes of erectile dysfunction are varied and may be due to physiological or emotional reasons. This study is designed to study the responsiveness of the erection quality scale (EQS) to vardenafil HCl. In this study, vardenafil HCl will be compared to placebo. Placebo is a pill which looks like the real drug but it is not. It contains no active ingredients.
Key facts
- Study ID
- NCT00665340
- Run by
- Bayer
- People needed
- 219
- Starts
- 2004-07-01
- Expected to finish
- 2005-01-01
- Last updated by the study team
- 2013-10-11
Who can join
Age: 18 and older, up to 64. Sex: male. Healthy volunteers: not accepted.
Where it is running
- Study site — Phoenix, Arizona, United States
- Study site — Beverly Hills, California, United States
- Study site — Laguna Hills, California, United States
- Study site — Newport Beach, California, United States
- Study site — Aurora, Colorado, United States
- Study site — Trumbull, Connecticut, United States
- Study site — Aventura, Florida, United States
- Study site — Lawrenceville, New Jersey, United States
- Study site — Poughkeepsie, New York, United States
- Study site — Statesville, North Carolina, United States
- Study site — Wilmington, North Carolina, United States
- Study site — Nashville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.